BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) announces 2b clinical trials!

Company Name:...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

QSI the good stock to buy? Important new development...
Sofinnova Venture Partners Picked Versartis Inc. (NA...
Here's Who Just Picked Up Taiwan Fund Inc. (NYSE:TWN...

Company Name: BELLUS Health Inc. 

Ticker: (BLU)

Exchange: NASDAQ

Website:  www.bellushealth.com

Company Summary:

BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of RCC and other hypersensitization-related disorders. The Company’s product candidate, BLU-5937, has successfully completed a Phase 2b trial in RCC and is planning a Phase 3 program that is expected to begin in 2022.

Why did it go up almost 100%?

Link HERE – LAVAL, Quebec, December 13, 2021–(BUSINESS WIRE)–BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and other hypersensitization-related disorders, today announced that the 50 mg and 200 mg BID doses of BLU-5937 in its Phase 2b SOOTHE trial for the treatment of RCC achieved statistical significance on the primary endpoint with 34% placebo-adjusted reduction in 24-hour cough frequency observed (p ≤ 0.005) at day 28. BLU-5937 was generally well-tolerated, with low rates of taste-related adverse events reported (≤6.5%) at all doses.

Mr. Roberto Bellini, Chief Executive Officer of BELLUS Health commented, “We are extremely pleased with the compelling topline results from the Phase 2b SOOTHE trial which highlight BLU-5937’s best-in-class potential for the treatment of refractory chronic cough. RCC is a prevalent and growing condition that significantly impacts the quality of life of an estimated 9 million patients in the United States and 9 million patients in Europe.”

5 Day Technical Analysis:

There are a lot of traders at $9.05, so if this stock can beat $9.05 tomorrow, I like it. If not, and I’m thinking it won’t, stay away. Caveat, the news is really good, so I hold out hope, but I don’t like the huge 70% gap up. Happy trading and always play it safe with trailing stops!

Stay in the lopp :

RADA stock price, is it time to sell or rebuy...

Rada Electronic Industries RADA stock price and chart looks great, is it time to sell or rebuy? Famed stock picker, Alexander Goldman has

Puget Technologies PUGE Stock Price is red ho...

Puget Technologies PUGE stock price is up 206% in the last 5 days, but is the run over for this breakout

Guess Who Picked Up Rli Corp. (NYSE:RLI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Rli Corp. (NYSE:RLI) reported that Kayne Anderson Rudnick Investment Management

related post

Skip to content